https:/#/nc.emagedd.www/ - Search

Články časopisu Dopamine receptor antagonists effects on low-dimensional attractors of local field potentials in optogenetic mice

Author of the article: Sorinel A. Oprisan, Xandre Clementsmith, Tamas Tompa, Antonieta Lavin Source: PLOS One | 10/2019 1. 10. 2019

Články časopisu Population productivity of shovelnose rays: Inferring the potential for recovery

Author of the article: Brooke M. D’Alberto, John K. Carlson, Sebastián A. Pardo, Colin A. Simpfendorfer Source: PLOS One | 11/2019 1. 11. 2019

Články časopisu Connectivity differences between Gulf War Illness (GWI) phenotypes during a test of attention

Author of the article: Tomas Clarke, Jessie D. Jamieson, Patrick Malone, Rakib U. Rayhan, Stuart Washington, John W. VanMeter, James N. Baraniuk Source: PLOS One | 12/2019 2. 12. 2019

Články časopisu The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder

Author of the article: Olivia Magwood, Ginetta Salvalaggio, Michaela Beder, Claire Kendall, Victoire Kpade, Wahab Daghmach, Gilbert Habonimana, Zack Marshall, Ellen Snyder, Tim O’Shea, Robin Lennox, Helen Hsu, Peter Tugwell, Kevin Pottie Source: PLOS One | 1/2020 2. 1. 2020

Články časopisu NEDD4 family ubiquitin ligases associate with LCMV Z’s PPXY domain and are required for virus budding, but not via direct ubiquitination of Z

Author of the article: Christopher M. Ziegler, Loan Dang, Philip Eisenhauer, Jamie A. Kelly, Benjamin R. King, Joseph P. Klaus, Inessa Manuelyan, Ethan B. Mattice, David J. Shirley, Marion E. Weir, Emily A. Bruce, Bryan A. Ballif, Jason Botten Source: PLOS Pathogens | 11/2019 1. 11. 2019

Články časopisu Advances and challenges in genetic technologies to produce single-sex litters

Author of the article: Charlotte Douglas, James M. A. Turner Source: PLOS Genetics | 7/2020 1. 7. 2020

Články časopisu Polo‑like Kinase 1 as a Target for Anti‑tumor Therapy

Author of the article: I. Procházková, B. Vojtěšek Source: Klinická onkologie | Supplementum 2/2015 10. 9. 2015

Články časopisu Radical external beam reirradiation of recurrent head and neck cancer

Author of the article: M. Švajdová, T. Kazda, P. Dubinský, P. Šlampa Source: Klinická onkologie | 2/2021 16. 4. 2021

Články časopisu Gunshot injury of the brain

Author of the article: M. Májovský, M. Häckel, N. Svoboda, V. Masopust, Z. Šňupárek, D. Netuka, V. Beneš Source: Česká a slovenská neurologie a neurochirurgie | 6/2019 30. 11. 2019

News How Does Empagliflozin Stand in Terms of Diabetic Retinopathy Risk? We Have Answers Not Only from Controlled Studies but Also from Real Practice

Modern antidiabetics –⁠ gliflozins and glucagon-like peptide-1 receptor agonists (GLP-1RA) –⁠ significantly help improve the management of type 2 diabetes (DM2). In addition to reliable glycemic control, they offer other benefits. For example, gliflozins are known for their cardio -⁠ and renoprotective properties. GLP-1RA also reduce cardiovascular (CV) risk, though clinical evaluation (SUSTAIN-6) suggests a possible higher risk of retinopathy. This is also being investigated with gliflozins. How empagliflozin fares in this respect has been shown by the prospective randomized EMPA-REG OUTCOME study and the real-world EMPRISE evaluation.

Source: Diabetes 5. 12. 2023

News Management of Adverse Effects During Maintenance Treatment of AML Patients

The randomized phase III study QUAZAR AML-001 evaluated the maintenance treatment of acute myeloid leukemia (AML) in patients after first remission. The following text summarizes the findings regarding the most common adverse events (AEs) in this therapy and practical recommendations for managing side effects based on guidelines from professional societies.

Source: Acute Myeloid Leukemia 4. 9. 2023

News Three tests to confirm the diagnosis of acquired hemophilia –⁠ infographic

Acquired hemophilia (AHA) typically manifests with spontaneous bleeding in patients with no prior personal history of significant bleeding.^1–4 The cause of the bleeding is a significant decrease in FVIII activity induced by autoantibodies against coagulation factor VIII.⁵ In polymorbid patients, established antithrombotic therapy at the time of AHA diagnosis may also contribute to the bleeding.⁴

Source: Acquired Hemophilia 8. 6. 2022

News Sequential Treatment of Schizophrenia –⁠ Interactive Case Study

Sequential treatment of schizophrenia helps psychiatrists clarify the stage of the patient's treatment and how to further guide pharmacotherapy. The following case study illustrates the possibilities for reducing negative and cognitive symptoms of schizophrenia while adhering to a metabolically sparing treatment approach.

Source: Modern Treatment of Schizophrenia 14. 9. 2023

News Thanks to Buccolam, the reality of suppressing convulsive seizures in children and adolescents approaches parents' ideal management

What crosses the mind of a parent when they notice their epileptic child or adolescent is having a convulsive seizure? They want it to be over quickly and safely. What constitutes the integral part that makes this wish a reality? And how does the newest treatment modality, buccally administered midazolam (Buccolam), address these needs?

Source: Quick aid for acute convulsive seizures in children and adolescents 25. 10. 2023

News Long-term survival of a 50-year-old man with metastatic pancreatic cancer on a combination of nal-IRI + 5-FU/LV in 2nd line treatment −⁠ case study

A recently published case study from the Czech Republic describes a patient with progression of pancreatic cancer following surgical treatment and adjuvant chemotherapy, who achieved a one-year survival with good quality of life on a combination of nal-IRI + 5-FU/LV after the failure of gemcitabine + nab-paclitaxel in the 1st line of palliative treatment.

Source: Treatment of Gastrointestinal Carcinomas 3. 6. 2024